Show simple item record

dc.contributor.authorHine, T.
dc.contributor.authorZhao, Yun
dc.contributor.authorBegley, A.
dc.contributor.authorSkeaff, S.
dc.contributor.authorSherriff, J.
dc.date.accessioned2018-02-19T07:58:30Z
dc.date.available2018-02-19T07:58:30Z
dc.date.created2018-02-19T07:13:30Z
dc.date.issued2018
dc.identifier.citationHine, T. and Zhao, Y. and Begley, A. and Skeaff, S. and Sherriff, J. 2018. Iodine-containing supplement use by pregnant women attending antenatal clinics in Western Australia.. Australian and New Zealand Journal of Obstetrics and Gynaecology.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/65492
dc.identifier.doi10.1111/ajo.12785
dc.description.abstract

BACKGROUND: Iodine requirements increase during pregnancy and although national recommendations for daily iodine supplementation (150 µg) exist, there is no research related to the uptake of these recommendations by pregnant women in Western Australia. AIMS: To investigate the use of iodine-containing supplements and associations with their use in a sample of Western Australian pregnant women. MATERIALS AND METHODS: A cross-sectional study was conducted on pregnant women attending antenatal clinics in a public tertiary hospital for women and neonates in Perth during 2012 and 2013 (n = 425). Women completed a self-administered questionnaire. Frequencies and percentages were obtained for categorical variables and ?2 tests conducted to assess associations between iodine-containing supplement use and sociodemographic and pregnancy-related factors. RESULTS: A total of 24% of pregnant women reported using iodine-containing supplements prior to pregnancy compared to 66% during the previous two months. Age and maternal income were associated with use prior to pregnancy only (P = 0.004 and P = 0.031) and first pregnancy was associated with use during pregnancy only (P = 0.006). Ethnicity and reporting use in the first two trimesters were associated with the use of iodine supplements both in the year prior to pregnancy (P = 0.002 and P = 0.020, respectively) and during pregnancy (P < 0.001 and P = 0.001, respectively). CONCLUSIONS: Two-thirds of women reported use of iodine-containing supplements during pregnancy, within the range reported for other Australian states. One-quarter reported use prior to pregnancy. Public health strategies are required to promote awareness of the importance of iodine and supplementation both before and during the entire pregnancy.

dc.publisherWiley-Blackwell Publishing Asia
dc.titleIodine-containing supplement use by pregnant women attending antenatal clinics in Western Australia.
dc.typeJournal Article
dcterms.source.issn1479-828X
dcterms.source.titleAustralian and New Zealand Journal of Obstetrics and Gynaecology
curtin.departmentSchool of Public Health
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record